Related Experiment Video
Updated: Nov 9, 2025

Probing Myosin Ensemble Mechanics in Actin Filament Bundles Using Optical Tweezers
Published on: May 4, 2022
Mechanical dysfunction of the sarcomere induced by a pathogenic mutation in troponin T drives cellular adaptation
Sarah R Clippinger1, Paige E Cloonan1, Wei Wang2
1Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, MO.
Insights
Familial hypertrophic cardiomyopathy (HCM) is driven by mutations affecting sarcomeric proteins. This study shows the R92Q mutation in troponin T alters tropomyosin positioning, increasing cellular force and driving HCM pathogenesis.
Area of Science:
- Cardiology
- Molecular Biology
- Biophysics
Background:
- Familial hypertrophic cardiomyopathy (HCM) is a primary cause of sudden cardiac death.
- HCM pathogenesis involves complex functional changes from molecular to tissue levels.
- Identifying the specific biophysical defect driving HCM is challenging.
Purpose of the Study:
- To investigate the R92Q mutation in troponin T, a known familial HCM mutation.
- To elucidate the primary molecular defect responsible for HCM pathogenesis.
- To link molecular alterations to downstream cellular and tissue-level changes.
Main Methods:
- Studied the R92Q mutation in troponin T.
- Analyzed mutation-induced alterations in tropomyosin positioning.
- Utilized computational modeling to assess cellular force generation.
- Examined downstream effects on gene expression, calcium handling, and electrophysiology.
Main Results:
- The R92Q mutation alters tropomyosin positioning.
- This alteration leads to increased molecular and cellular force generation during calcium activation.
- Computational models confirm the link between molecular changes and increased cellular force.
- Downstream effects include altered gene expression, calcium handling, and electrophysiology.
Conclusions:
- Mutation-induced changes in mechanical tension are the primary drivers of familial HCM pathogenesis.
- Increased cellular contractility activates adaptive mechanobiological signaling pathways.
- Understanding these molecular mechanisms is crucial for developing targeted therapies for HCM.
Abstract:
Familial hypertrophic cardiomyopathy (HCM), a leading cause of sudden cardiac death, is primarily caused by mutations in sarcomeric proteins. The pathogenesis of HCM is complex, with functional changes that span scales, from molecules to tissues. This makes it challenging to deconvolve the biophysical molecular defect that drives the disease pathogenesis from downstream changes in cellular function. In this study, we examine an HCM mutation in troponin T, R92Q, for which several models explaining its effects in disease have been put forward. We demonstrate that the primary molecular insult driving disease pathogenesis is mutation-induced alterations in tropomyosin positioning, which causes increased molecular and cellular force generation during calcium-based activation. Computational modeling shows that the increased cellular force is consistent with the molecular mechanism. These changes in cellular contractility cause downstream alterations in gene expression, calcium handling, and electrophysiology. Taken together, our results demonstrate that molecularly driven changes in mechanical tension drive the early disease pathogenesis of familial HCM, leading to activation of adaptive mechanobiological signaling pathways.
Related Concept Videos
The Sarcomere
Each...
Cross-bridge Cycle
Actin and Myosin in Muscle Contraction
Excitation-Contraction Coupling in Skeletal Muscles
When an action...
Overview of Skeletal Muscle
Actin Polymerization and Cell Motility
Actin cytoskeleton dynamics can produce pushing, pulling, and resistance forces that help the cell to migrate....

